GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
122 hedge funds and large institutions have $826M invested in Genomic Health, Inc. in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 59 increasing their positions, 23 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
9% more funds holding
Funds holding: 112 → 122 (+10)
8% less capital invested
Capital invested by funds: $901M → $826M (-$74.4M)
Holders
122
Holding in Top 10
3
Calls
$1.33M
Puts
$1.1M
Top Buyers
| 1 | +$32.9M | |
| 2 | +$11.3M | |
| 3 | +$6.4M | |
| 4 |
Goldman Sachs
New York
|
+$4.59M |
| 5 |
Millennium Management
New York
|
+$4.29M |
Top Sellers
| 1 | -$45.8M | |
| 2 | -$30.8M | |
| 3 | -$8.84M | |
| 4 |
TA
Teachers Advisors
New York
|
-$2.98M |
| 5 |
BC
Broadfin Capital
New York
|
-$2.29M |